Skip to Content

Regencell Bioscience Holdings Limited 

Securities Class Action

  • Date:
  • 11/12/2025
  • Company Name:
  • Regencell Bioscience Holdings Limited
  • Stock Symbol:
  • RGC
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ:RGC) on behalf of Regencell stockholders. Our investigation concerns whether Regencell has violated the federal securities laws and/or engaged in other unlawful business practices.


On October 31, 2025, Regencell disclosed in a filing with the U.S. Securities and Exchange Commission that "following recent volatility in the market for our Ordinary Shares, the Company received correspondence and a subpoena from the U.S. Department of Justice (‘DOJ'), indicating that the DOJ is conducting an investigation into the trading in our Ordinary Shares." Regencell said that "[t]he DOJ has requested the production of documents and communications concerning these and other corporate operational, financial and accounting matters" and that the Company "expect[s] to continue to incur significant legal costs and other expenses in connection with responding to the investigation" and "may be required to pay fines, penalties, damages or settlement costs in excess of our insurance coverage, if any, related to the investigation." 

On this news, Regencell's stock price fell $3.09 per share, or 18.56%, to close at $13.56 per share on November 3, 2025.

If you purchased or otherwise acquired Regencell shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions regarding the case.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Regencell Bioscience Holdings Limited. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: